9 June 2026 in IEEE Transactions on Instrumentation and Measurement
Stroke is a leading cause of mortality and disability worldwide, with rapid diagnosis critical for effective intervention. Conventional imaging modalities such as CT and MRI are limited by their size, cost, and unsuitability for bedside or prehospital emergency use. This study presents a novel Superparamagnetic Iron Oxide Nanoparticles (SPIOs) based Magnetic Induction Tomography (SPIO-MIT) for non-invasive stroke-tracing imaging. Operating at an ultra-low excitation frequency of 3 kHz and a magnetic field strength below 1 mT, the system effectively suppresses background interference from biological tissues while enhancing sensitivity to SPIOs distribution. System performance was validated through phantom experiments featuring varied SPIOs positions, geometries, and concentration gradients, confirming accurate imaging of SPIOs with negligible response to low-conductivity substances. Complementary in vitro experiments embedding SPIO-blood mixtures in biological tissues demonstrated minimal background interference. In vivo experiments on a rabbit intracerebral hemorrhage model further confirmed precise localization of SPIOs injected into the brain, with detection sensitivity down to 1.2 mg of iron and an imaging diameter of 60 mm. In summary, the developed SPIO-MIT system enables sensitive, non-invasive spatial mapping of SPIOs. By combining the high sensitivity of magnetic particle imaging with the operational simplicity and biological safety of magnetic induction tomography, SPIO-MIT represents a promising technique for portable, bedside, and prehospital stroke diagnostics.